0HNC.L • LSE
Unlock comprehensive alternative data signals to make better investment decisions

Track website visits, page views, unique visitors, and engagement metrics over time to gauge online interest and brand strength.

Monitor Twitter follower growth, engagement rates, and social media presence to understand brand reach and community sentiment.

Analyze TikTok follower trends and viral content performance to measure youth demographic appeal and cultural relevance.

Track Facebook page likes, comments, shares, and post engagement to assess community interaction and brand loyalty.

Monitor Instagram follower growth, engagement rates, and visual content performance across demographics.

Track YouTube channel growth, video views, and subscriber engagement to measure content marketing effectiveness.

Monitor LinkedIn company page followers and professional network growth to assess B2B brand strength and talent attraction.

Track open job positions and hiring trends as a leading indicator of company expansion, contraction, or strategic shifts.

Monitor employee headcount changes on LinkedIn to gauge organizational growth, restructuring, or cost-cutting measures.

Analyze sentiment scores from Reddit discussions to understand retail investor mood and potential price momentum.

Track daily news mentions across major publications to measure media attention, PR effectiveness, and market awareness.

View key financial metrics including Revenue, Net Income, EPS, Free Cash Flow, EBITDA, and Total Assets. Access 2-year quarterly charts for Revenue & Income and Free Cash Flow trends.

Analyze technical indicators including 50-day Simple Moving Average (SMA) with price overlay and Relative Strength Index (RSI) charts.
TrendEdge provides tools and data for research and educational purposes only and does not provide investment advice or personal recommendations.
You don't hold 0HNC.L in your mock portfolio yet.
The combination of a very high P/E ratio (283.77) and low EPS (0.22) suggests that current profitability is weak relative to the stock price and that the market is pricing in substantial future growth. Without evidence of strong, accelerating earnings, this valuation looks stretched and vulnerable to disappointment. Profitability appears thin, and the risk/reward skew is unfavorable if earnings growth does not materialize.
The stock has gained 14.7% over the last month, showing short-term positive momentum, and the RSI at 63.20 indicates bullish but not yet overbought conditions. However, the current price of $61.01 is still well below the 200-day moving average of $89.61, signaling that the longer-term trend remains down or that the stock is in a recovery phase from prior weakness. Overall, technicals point to a rebound within a still-challenged longer-term trend.
Alternative data for BioMarin Pharmaceutical Inc. shows stability rather than strong acceleration. Web traffic is flat month over month, job openings are up slightly, and social media followings are growing modestly from a relatively small base on most platforms (with the exception of LinkedIn). These signals collectively suggest a steady, but not rapidly expanding, commercial and corporate footprint.
BioMarin Pharmaceutical Inc.’s stock currently presents a mixed picture: short-term technical momentum has improved, but long-term technicals and fundamentals remain challenged by a very high valuation versus modest earnings. Alternative data signals are broadly stable, not clearly confirming a strong growth inflection. Overall, the balance of evidence supports a neutral stance, with meaningful upside dependent on future earnings and pipeline execution catching up to the current valuation.
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals.
Key moves vs recent baseline (last day / last week)
Plain-English summary of the biggest drivers (informational)
Potential risk factors to review
Based on earnings timing, volatility, liquidity and crowd activity. Informational signals only — not investment advice.
Reassess your thesis if any of these occur: